FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Iterum Therapeutics plc Stock AnalysisComprehensive stock analysis for Iterum Therapeutics plc (ITRM) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisITRM
ITRM
Iterum Therapeutics plc
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
ITRM
Home🔹Stocks🔹Iterum Therapeutics plc

Iterum Therapeutics plc

ITRM•NASDAQ

Iterum Therapeutics plc

ITRM•NASDAQ
Market cap
$1.60M
Sentiment

Your view on ITRM

Mkt Cap
$1.60M
Sentiment
Your view
ITRM
Iterum Therapeutics plc
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
ITRM
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Iterum Therapeutics plc

Industry
Biotechnology
Sector
Healthcare
CEO
Corey N. Fishman
Headquarters
Fitzwilliam Court, Dublin, IE
Industry
Biotechnology
Sector
Healthcare
CEO
Corey N. Fishman
Headquarters
Fitzwilliam Court, Dublin, IE
Description

Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News